VBCVX Performance — Systematic Value Fund
Data updated: 2026-09-28
VBCVX returned +11.77% year to date and +25.54% over one year to May 2026. Annualised returns are +20.14% over 3 years and +11.53% over 5 years. The fund beat its US Large Value category average: $100 invested three years ago grew to $173, against $165 for the category, and to $126 over one year, against $124. Volatility over the past three years was 12.46% a year. In the 12 months to May 2026 the fund took in a net $121.4M, and assets reached $653.16M.
VBCVX Growth of $100
What $100 invested in Systematic Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | VBCVX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $126 | $124 |
| 3 years (Jun 2023 – May 2026) | $173 | $165 |
| 5 years (Jun 2021 – May 2026) | $173 | $163 |
| Since data start (Sep 2019 – May 2026) | $220 | $223 |
VBCVX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.77% |
| 1 year | +25.54% |
| 3 years (annualised) | +20.14% |
| 5 years (annualised) | +11.53% |
VBCVX Annual Returns
Calendar-year total returns of Systematic Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +11.77% |
| 2025 | +17.41% |
| 2024 | +16.74% |
| 2023 | +11.18% |
| 2022 | −6.67% |
| 2021 | +30.95% |
| 2020 | −2.90% |
| 2019 (Sep–Dec) | +8.68% |
VBCVX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.9% | +1.6% | −4.8% | +6.8% | +4.2% | — | — | — | — | — | — | — |
| 2025 | +4.1% | +0.6% | −2.5% | −2.0% | +4.5% | +3.0% | +0.9% | +2.7% | +1.9% | −0.7% | +3.1% | +0.9% |
| 2024 | +0.8% | +3.6% | +5.5% | −4.9% | +3.5% | −0.9% | +5.1% | +3.4% | +1.1% | −0.2% | +6.2% | −6.7% |
| 2023 | +5.3% | −2.5% | −1.0% | +0.2% | −3.6% | +7.1% | +3.1% | −1.5% | −3.7% | −3.6% | +6.7% | +5.2% |
| 2022 | −2.9% | −1.9% | +2.7% | −5.2% | +2.8% | −7.7% | +6.8% | −3.6% | −8.4% | +9.8% | +6.3% | −3.8% |
| 2021 | −0.3% | +4.3% | +6.8% | +5.2% | +3.2% | −0.4% | +1.8% | +2.2% | −3.7% | +4.8% | −2.8% | +6.7% |
| 2020 | −1.9% | −8.8% | −17.2% | +11.3% | +3.8% | −2.1% | +2.4% | +3.8% | −3.0% | −3.4% | +12.8% | +3.2% |
| 2019 | — | — | — | — | — | — | — | — | +2.7% | +0.9% | +3.9% | +0.9% |
VBCVX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 12.46%
- 3-year Sharpe ratio: 1.26 (vs 4.5% risk-free rate)
- Best month: +7.08% (Jun 2023)
- Worst month: −6.70% (Dec 2024)
VBCVX Fund Flows
Monthly money in and out of Systematic Value Fund, from SEC Form N-PORT.
- 12-month net flow: $121.4M
- 12-month gross sales (incl. reinvestments): $205.7M
- Sales ÷ redemptions: 2.44×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $12.6M | $10.3M | $2.3M |
| Apr 2026 | $9.7M | $5.2M | $4.5M |
| Mar 2026 | $104.1M | $554K | $103.6M |
| Feb 2026 | $25.4M | $19.2M | $6.2M |
| Jan 2026 | $46.1M | $701K | $45.4M |
| Dec 2025 | $3.1M | $14.4M | −$11.2M |
| Nov 2025 | $468K | $4.8M | −$4.3M |
| Oct 2025 | $700K | $5.9M | −$5.2M |
| Sep 2025 | $1.6M | $6.2M | −$4.6M |
| Aug 2025 | $355K | $7.0M | −$6.7M |
| Jul 2025 | $584K | $4.5M | −$3.9M |
| Jun 2025 | $799K | $5.5M | −$4.7M |
VBCVX Assets Under Management
Net assets of Systematic Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $653.16M |
| 2026-02-28 | $550.97M |
| 2025-11-30 | $479.29M |
| 2025-08-31 | $473.48M |
| 2025-05-31 | $458.17M |
| 2025-02-28 | $463.05M |
| 2024-11-30 | $479.88M |
| 2024-08-31 | $475.70M |
| 2024-05-31 | $454.82M |
| 2024-02-29 | $457.80M |
| 2023-11-30 | $428.05M |
| 2023-08-31 | $423.13M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.